Zentalis Pharmaceuticals, Inc. business relationships
Companies named in Zentalis Pharmaceuticals, Inc.’s 10-K filed 2026-03-26, and public companies whose annual reports name Zentalis Pharmaceuticals, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- <1 / 100 Top 16% in its category
- Agent readiness
- 40 / 100
- AI adoption
- 0 / 100
Named in Zentalis Pharmaceuticals, Inc.’s annual report 6
“For example, we have collaborated with Pfizer, GSK and Dana Farber on the development of azenosertib.” SEC filing
“For example, we have collaborated with Pfizer, GSK and Dana Farber on the development of azenosertib.” SEC filing
“In April 2021, we entered into a clinical trial collaboration and supply agreement with GSK under which we have evaluated the combination of azenosertib and niraparib, GSK's poly (ADP-ribose) polymerase (PARP) inhibitor, in patients” SEC filing
“The Company determined that the Immunome License Agreements fall within the scope of ASC 606, Revenue from Contracts with Customers (ASC 606) as Immunome has contracted to obtain goods and services that are an output of ordinary activities and is a customer.” SEC filing
“The assets subject to the Immunome Asset Sale Agreement were previously licensed to Immunome under the Immunome License Agreement.” SEC filing
“In January 2024, we entered into an exclusive, worldwide license agreement with Immunome, or the Immunome License Agreement, under which Immunome licensed from us ZPC-21 (now known as IM-1021), a preclinical ROR1 ADC with best-in-class potential, and our proprietary ADC platform technology, or the A...” SEC filing
Companies whose annual reports name Zentalis Pharmaceuticals, Inc. 1
“On January 5, 2024, the Company entered into a license agreement with Zentalis Pharmaceuticals, Inc., or the Zentalis License Agreement, pursuant to which the Company received an exclusive, worldwide, royalty-bearing, sublicensable license under certain intellectual property relating to Zentalis' pr...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.